Taro Pharmaceutical Industries Shares Near 52-Week Low - Market Mover
The shares closed 1.4% above its 52-week low of $45.00, with trading volume higher than its 30 day average
Jan 04, 2022 by Kwhen Finance Editors
Taro Pharmaceutical Industries (TARO) shares closed today at 1.4% above its 52 week low of $45.00, giving the company a market cap of $1B. The stock is currently down 9.0% year-to-date, down 37.9% over the past 12 months, and down 51.5% over the past five years. This week, the Dow Jones Industrial Average rose 0.8%, and the S&P 500 rose 0.1%.
Trading Activity
- Trading volume this week was 15.0% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Taro Pharmaceutical Industries | -9.0 | -9.0 | -37.9 | -37.4 | 11.4 |
| Dow Jones Industrial Average | 0.6 | 0.6 | 21.6 | -0.6 | 24.0 |
| S&P 500 Index | 0.6 | 0.6 | 29.5 | -0.5 | 31.2 |
| Health Care | -0.9 | -0.9 | 22.3 | -0.8 | 27.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by -8230.7%
- The company's stock price performance over the past 12 months lags the peer average by -389.0%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries | TARO | 0 | -9.0 | -37.9 | -37.4 | 11.4 |
| Peer Avg | N/A | 22.6 | 0.1 | 13.1 | -12.2 | 93.1 |
| Johnson & Johnson | JNJ | 25.3 | 0.3 | 11.7 | -4.3 | 14.5 |
| Pfizer Inc. | PFE | 16.6 | -4.1 | 59.9 | -5.2 | 80.3 |
| Novartis AG - ADR | NVS | 37.1 | 0.5 | -3.2 | -8.0 | 10.3 |
| Merck & Co Inc | MRK | 26.9 | 0 | -2.9 | -15.5 | 412.9 |
| Glaxosmithkline plc - ADR | GSK | 17.1 | 0 | 26.8 | -1.0 | 36.7 |
| Teva- Pharmaceutical Industries Ltd. - ADR | TEVA | 12.7 | 4.0 | -13.7 | -39.5 | 4.1 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: